
Indraneel Deshmukh, M.B.B.S
@torsadepointles
MPH Epi @UThealthSPH @UTHealthHouston '25. Clinical Outcomes Research @MDAndersonNews Dept of Leukemia. Alum - M.B.B.S/MD @LtmmcM & GH , Mumbai’23 #Match2026
ID: 1494759298424991745
18-02-2022 19:42:55
7,7K Tweet
2,2K Followers
3,3K Following


View from Tata Memorial Hospital today afternoon. Never seen Mumbai like this in the “summer month” of May!!




👉👉👉 #ASCO25 | New #CD123 antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer | MD Anderson Cancer Center Naveen Pemmaraju, MD Naval Daver, M.D. MD Anderson Cancer Center #BPDCN #Endcancer mdanderson.org/newsroom/2025/…




👉The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms | Leukemia | Kuhn, M Naveen Pemmaraju, MD FlorianHeidel #MPNSM #leusm Leukemia Journal nature.com/articles/s4137…









Very much looking forward to this meeting. Looking forward to great discussions and presentations from key US and international leaders on AML & ALL. Hoping you can join! MD Education Jessica Altman, MD Tapan Kadia Naveen Pemmaraju, MD Rami komrokji


What a conference MD Education. Incredible discussion covering EVERY single phase of contemporary AML management. Here are 11 interesting pearls, controversies, and future-facing insights from true global experts.🧵👇 #leusm #AML
